Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-10-23
2007-10-23
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S543000, C540S581000
Reexamination Certificate
active
10403506
ABSTRACT:
The present invention concerns a compound of formula (I)wherein:W represents O or NH,Q represents an unbranched or branched, saturated or unsaturated or aromatic, cyclic or acyclic or heterocyclic hydrocarbon radical containing 1 to 30 carbon atoms including or not heteroatom(s),R1is H, OH, or R1, R2form together —O—,R3═R4═OMe or R3and R4form together —OCH2O—,R is H, C1-C30alkyl or O-protecting group and R6represents an unbranched or branched, saturated or unsaturated or aromatic, cyclic or acyclic or heterocyclic hydrocarboned radical containing 1 to 30 carbon atoms including or not heteroatom(s), or R and R6form together —CMe2-,n is 0 to 8,R5is H, OH, OMe, O—(C1-C30)-alkyl, O-aryl-(C1-C30)-alkyl, O—(C2-C30)-alkenyl, O—(C3-C30)-cycloalkyl or O-aryl,the dotted line is null or forms a double bond depending on the meaning of R1.It also concerns their methods of preparation and their use in treatment of cancers, leukemias, parasites and as reversal agents of harringtonines.
REFERENCES:
patent: 6579869 (2003-06-01), Robin et al.
patent: WO99/48894 (1999-09-01), None
Kano et al., In Vitro Cytotoxic Effects of a Tyrosine Kinase Inhibitor STI571 in Combination With Commonly Used Antileukemic Agents, Blood, vol. 97, No. 7, pp. 1999-2007, Apr. 1, 2001.
O'Brien et al., Sequential Homoharringtonine and Interferon-.alpha. in the Treatment of Early Chronic Phase Chronic Myelogenous Leukemia, Blood, vol. 93, No. 12, pp. 4149-4153, Jun. 15, 1999.
Medline abstract of Witte et al., A Phase II Trial of Homoharringtonine and Caracemide in the Treatment of Patients With Advanced Large Bowel Cancer, New Drugs, vol. 17, No. 2, pp. 173-177, 1999.
Takano et al., Drupangtonine, A Novel Antileukemic Alkaloid From Cephalotaxus Harringtonia Var. Drupacea, Bioorganic & Medicinal Chemistry Letters, vol. 6, No. 14, pp. 1689-1690, 1996.
Kelly et al., Preparation of Harringtonine from Cephalotaxine, Journal of Organic Chemistry, vol. 44, No. 1, pp. 63-67, 1979.
Jiachong Cheng et al, “Stereospecific synthesis of deoxyharringtonine and homoharringto-nine”, Chemical Abstracts, Accession No. 103:160738, XP002163590, Abstract; Figure 313, & Yoaxue Xuebao (1984) 19(3), 178-83.
Hiroshi Morita et al, “Cephalezomines A-F, potent cytotoxic alkaloids from Cephalotaxus harringtonia var. nana”,Tetrahedron(2000), 56(19), 2929-2934, XP004198001.
Ichiro Takano et al, “New Cephalotaxus Alkaloids from Cephalotaxus harringtonia var. drupacea”,J. Nat. Prod.(1996), 59(10), 965-967, XP002163587.
Yongkeng Wang et al, “Synthesis of homoharringtonine and separation of its stereomers”, Database accession No. 103:71569, XP002163591, Abstract; Figure 315 & Huaxue Xuebao (1985), 43(2), 161-7.
Sayoko Hiranuma et al, “Studies in Cephalotaxus Alkaloids, Stereospecific Total Synthesis of Homoharringtonine”,J. Org. Chem.(1983), 48(26), 5321-6, XP002087582.
Puzhu Cong, “Mass spectroscopic study of cephalotaxine alkaloids”, Chemical Abstracts, Database accession No. 99:54042, XP002163592, Abstract; Figure 318 & Yaoxue Xuebao (1983), 18(3), 215-226.
S. Hiranuma et al, “Synthesis of Hemoharringtonine and its Derivative by Partial Esterificaiton of Cephalotaxine”,Tetrahedron Lett.(1982), 23(34), 3431-4, XP002163588.
Yulin Li et al, “New synthetic method for harringtonine”, Chemical Abstracts, Database accession No. 98:16906, XP002163593, Abstract; Figure 324 & Lanzhou Daxue Xuebao, Ziran Kexueban (1982), 18(3), 126.
Shu-Wen Li et al, “A study on the deoxyharringtonine and its analogs”, Chemical Abstracts, Database accession No. 85:108857, XP002163594, Abstract; Figure 328 & Hua Hsueh Hsueh Pao (1975), 33(1), 75-8.
K. L. Mikolajczak et al, “Partial synthesis of harringtonine analogs”,J. Pharm. Sci., (1974), 63(8), 1280-3, XP002163589.
PCT/IB 00/01593 International Search Report, date of mailing: Apr. 12, 2001.
CAPLUS Printout for Cheng et al., Stereospecific Synthesis of Deoxyharringtonine and Homoharringtonine, Yaoxue Xuebao, vol. 19, No. 3, pp. 178-183, 1984.
He et al., Stability-Indicating LC Assay of and Impurity Identification in Homoharringtonine Samples, Journal of Pharmaceutical and Biomedical Analysis, vol. 22, No. 3, pp. 541-544, 2000.
Bataille Patricia
Dhal Robert
Drouye Freddy
Marie Jean-Pierre
Radosevic Nina
Coleman Brenda
Stragen Pharma S.A.
LandOfFree
Cephalotaxanes, their method of preparation and their use in... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cephalotaxanes, their method of preparation and their use in..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cephalotaxanes, their method of preparation and their use in... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3832317